AJO LP’s Larimar Therapeutics LRMR Stock Holding History

AJO LP’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,821	Closed	-$102K	–	609
2017 Q1	$102K	Sell	1,821 -177	-9%	-$8.79K	﹤0.01%	515
2016 Q4	$76K	Sell	1,998 -219	-10%	-$8.88K	﹤0.01%	514
2016 Q3	$88K	Buy	+2,217	New	+$101K	﹤0.01%	509

Other funds holding LRMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

AJO LP's LRMR Position: Q2 2017 in Review

AJO LP sold out of Larimar Therapeutics (LRMR) in Q2 2017, closing a stake of 1,821 shares — an estimated $102K sold.

AJO LP first reported a position in LRMR in Q3 2016 and held it in 3 quarters. The position peaked at $102K in Q1 2017. 69 funds tracked by Wall St. Rank hold LRMR as of Q2 2017.

AJO LP reported no remaining Larimar Therapeutics position as of Q2 2017 after selling out during the quarter.
AJO LP sold 1,821 Larimar Therapeutics shares in Q2 2017, an estimated $102K.
AJO LP first reported a position in Larimar Therapeutics in Q3 2016 and held it in 3 quarters.
AJO LP's Larimar Therapeutics position peaked at $102K in Q1 2017.
69 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2017.

Based on AJO LP's 13F filing for Q2 2017, filed 10 Aug 2017.